Paper Details

  1. Home
  2. Paper Details

English version of Japanese guidance for use of biologics for psoriasis (the 2022 version).

Author: , AbeMasatoshi, AsahinaAkihiko, IgarashiAtsuyuki, ImafukuShinichi, KomineMayumi, MabuchiTomotaka, MoritaAkimichi, OhtsukiMamitaro, OkuboYukari, SaekiHidehisa, SanoShigetoshi, ToriiHideshi, WatanabeAkira, YotsuyanagiHiroshi

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.

Overview

This guidance provides recommendations for the appropriate use of biologics in the treatment of psoriasis in Japan. It emphasizes the importance of selecting the most suitable biologic therapy for each patient based on disease factors, treatment factors, and patient background factors. The guidance outlines key considerations for selecting biologics, including drug effects, safety, convenience, and cost.
Paper Details　
Original Abstract of the Article :
This is the English version of Japanese guidance for use of biologics for psoriasis (the 2022 version). As the first biologics for psoriasis in Japan, infliximab and adalimumab, anti-tumor necrosis factor-α antibodies, became available in the field of dermatology in 2010, followed by ustekinumab, an...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1111/1346-8138.16691

データ提供：米国国立医学図書館（NLM）

Biologics for Psoriasis: Navigating the Desert of Skin Disease

Psoriasis, a chronic skin condition characterized by scaly, inflamed patches, can be a real desert of discomfort for those who suffer from it. This document, like a guidebook for a camel caravan, provides insights into the use of biologics, a class of medications that target specific molecules involved in inflammation, in the treatment of psoriasis. The document reviews the various biologics currently available for psoriasis, outlining their mechanisms of action, effectiveness, safety profiles, and considerations for selecting the most appropriate treatment for individual patients. It emphasizes the importance of individualized treatment plans based on disease factors, treatment factors, and patient background factors.

A Path Forward in the Desert of Psoriasis

This document provides a valuable resource for healthcare professionals and patients navigating the landscape of psoriasis treatment. The information presented can help guide decisions regarding the use of biologics, ensuring that patients receive the most appropriate and effective treatment for their individual needs. It underscores the importance of a collaborative approach to managing psoriasis, with open communication between patients and their healthcare providers.

Living with Psoriasis: Finding Oasis in the Desert

Psoriasis, while a challenging condition, can be effectively managed with the right approach. Working with a healthcare professional to develop an individualized treatment plan, including medications, lifestyle modifications, and supportive care, is crucial for finding oasis in the desert of psoriasis.

Dr. Camel's Conclusion

Biologics for psoriasis offer a diverse range of treatment options, providing a potential oasis for individuals seeking relief from this challenging skin condition. This document serves as a valuable guide for navigating the landscape of psoriasis treatment, emphasizing the importance of individualized care and a collaborative approach between patients and their healthcare providers.
Date :
  1. Date Completed 2023-02-03
  2. Date Revised 2023-02-23
Further Info :

Pubmed ID

36582113

DOI: Digital Object Identifier

10.1111/1346-8138.16691

Related Literature

Article Analysis
・Effects of brodalumab injection
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.